Domača stranMEDP • NASDAQ
add
Medpace Holdings Inc
330,91 $
Po zaprtju:(0,00 %)0,00
330,91 $
Konec trgovanja: 14. jan., 16:15:28 GMT -5 · USD · NASDAQ · Izjava
Prejšnji trg. dan.
352,01 $
Dnevni razpon
327,00 $ - 345,04 $
Letni razpon
277,72 $ - 459,77 $
Tržna kapitalizacija
10,29 mrd. USD
Povprečni obseg
230,42 tis.
Razm. P/E
28,98
Dividendna donosnost
-
Primarna borza
NASDAQ
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 533,32 mio. | 8,29 % |
Stroški poslovanja | 249,50 mio. | 2,58 % |
Čisti dohodek | 96,43 mio. | 36,68 % |
Čista dobičkovnost prihodkov | 18,08 | 26,26 % |
Earnings per share | 3,01 | 34,81 % |
EBITDA | 119,79 mio. | 30,51 % |
Efektivna davčna stopnja | 18,82 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 656,90 mio. | 589,97 % |
Skupna sredstva | 2,08 mrd. | 40,18 % |
Skupne obveznosti | 1,20 mrd. | 18,39 % |
Celoten lastniški kapital | 881,44 mio. | — |
Shares outstanding | 31,01 mio. | — |
Razmerje P/B | 12,39 | — |
Donosnost sredstev | 14,02 % | — |
Donosnost kapitala | 28,78 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 96,43 mio. | 36,68 % |
Denar iz dejavnosti | 149,08 mio. | 30,33 % |
Denar iz naložb | −10,49 mio. | −21,06 % |
Denar iz financiranja | 6,27 mio. | 112,73 % |
Neto sprememba denarnih sredstev | 146,01 mio. | 160,40 % |
Prost denarni tok | 111,39 mio. | 19,66 % |
Vizitka
Medpace Holdings, Inc. is a global clinical research organization based in Cincinnati, Ohio, employing approximately 5,400 people. Medpace's mission statement is "to accelerate the global development of safe and effective medical therapeutics" through its high science and disciplined operating approach that leverages local, regulatory, and deep therapeutic expertise across all major areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective. Operating under a full-service model, Medpace provides a therapeutically focused, integrated, global approach to clinical development. The company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.
The company started trading stock as a public firm in 2016. Wikipedia
Generalni direktor
Datum ustanovitve
1992
Sedež organizacije
Spletno mesto
Zaposleni
5.900
